481 results on '"Eller, Kathrin"'
Search Results
2. Clinical-Pathological Conference Series from the Medical University of Graz: Case No 178: A 30-year-old nurse with urine dipstick (+++)‑positive for protein in her late pregnancy
3. Homocysteine contributes to atherogenic transformation of the aorta in rabbits in the absence of hypercholesterolemia
4. Continuous Insulin Therapy to Prevent Post-Transplant Diabetes Mellitus: A Randomized Controlled Trial
5. Diagnostik und Therapie der Minimal Change Glomerulopathie beim Erwachsenen – 2023
6. Diagnostik und Therapie IgA Nephropathie – 2023
7. Diagnose und Therapie glomerulärer Erkrankungen mit einem membranoproliferativen Läsionsmuster (MPGN) – 2023
8. Allgemeine Empfehlungen für die Behandlung glomerulärer Erkrankungen – 2023
9. Diagnostik und Therapie der Lupusnephritis – 2023
10. Diagnose und Therapie der Granulomatose mit Polyangiitis und mikroskopische Polyangiitis – 2023: Konsens-Empfehlungen der Österreichischen Gesellschaften für Nephrologie (ÖGN) & Rheumatologie (ÖGR)
11. Diagnostik und Therapie der Membranösen Nephropathie – 2023
12. Diagnostik und Therapie der Fokal-Segmentalen Glomerulosklerose – 2023
13. Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange
14. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT
15. Biomarkers of alcohol abuse potentially predict delirium, delirium duration and mortality in critically ill patients
16. Management of Immune Thrombotic Thrombocytopenic Purpura without Therapeutic Plasma Exchange
17. Pre-Transplant Frequencies of FoxP3+CD25+ in CD3+CD8+ T Cells as Potential Predictors for CMV in CMV-Intermediate Risk Kidney Transplant Recipients
18. #2084 Biologic effect evaluation of de novo long-term release tacrolimus on metabolizer phenotype and T cell composition after kidney transplantation
19. #1680 Cardiovascular disease in kidney transplant recipients with post-transplant diabetes mellitus—retrospective analysis from a randomized trial
20. #1491 Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange
21. Differences in drug removal between standard high-flux and medium cut-off dialyzers in a case of severe vancomycin toxicity
22. Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
23. Glucometabolism in Kidney Transplant Recipients with and without Posttransplant Diabetes: Focus on Beta-Cell Function
24. International consensus on post-transplantation diabetes mellitus
25. Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis
26. Immunologically relevant aspects of the new COVID-19 vaccines—an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper
27. Rituximab in Membranous Nephropathy
28. Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial.
29. Pre-Transplant Frequencies of FoxP3+CD25+ in CD3+CD8+ T Cells as Potential Predictors for CMV in CMV-Intermediate Risk Kidney Transplant Recipients.
30. Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation
31. Changes in cardiac troponins during hemodialysis depend on hemodialysis membrane and modality: a randomized crossover trial
32. Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series
33. MicroRNA-142-3p improves vascular relaxation in uremia
34. Changes in cardiac troponins during hemodialysis depend on hemodialysis membrane and modality: a randomized crossover trial.
35. Homocysteine contributes to atherogenic transformation of the aorta in rabbits in the absence of hypercholesterolemia
36. COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
37. Reduced COVID-19 morbidity and mortality in hemodialysis patients across the various Omicron sublineages—A retrospective analysis
38. Influence of Early Postoperative Basal Insulin Treatment and Post-Transplant Diabetes Mellitus Risk on Health-Related Quality of Life in Kidney Transplant Recipients—An Analysis of Data From a Randomized Controlled Trial
39. Diagnosis and therapy of membranous nephropathy—2023
40. Diagnosis and treatment of focal-segmental glomerulosclerosis—2023
41. #4574 ATYPICAL CHEMOKINE RECEPTOR 4 IS EXPRESSED IN GLOMERULAR PARIETAL EPITHELIAL CELLS AND MITIGATES THE SEVERITY OF EXPERIMENTAL GLOMERULONEPHRITIS
42. COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
43. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT
44. Hospitalizations, emergency room visits and causes of death in 198 patients with permanent hypoparathyroidism: a retrospective Austrian study (2005–2022)
45. A Multicentre, Patient- and Assessor-blinded, Non-inferiority, Randomised and Controlled Phase Ii Trial to Compare Standard and Torque Teno Virus-guided Immunosuppression in Kidney Transplant Recipients in the First Year After Transplantation: Ttv Guide It
46. Management of Immune Thrombotic Thrombocytopenic Purpura Without Therapeutic Plasma Exchange
47. Additional file 6 of A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT
48. Additional file 2 of A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT
49. Additional file 3 of A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT
50. Additional file 8 of A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.